Vasoactive intestinal peptide (VIP) in patients with critical COVID 19 respiratory failure.

Ruchalla, E.

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Vasoactive intestinal peptide (VIP) in patients with critical COVID 19 respiratory failure.

Ruchalla, E..

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie ; 58(3):126-127, 2023.

Article in German | EMBASE | ID: covidwho-2302805

Keywords

coronavirus disease 2019/dt [Drug Therapy]; human; note; respiratory failure; vasoactive intestinal polypeptide/dt [Drug Therapy]

Fulltext

Print

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: EMBASE Language: German Journal: Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

Print

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: EMBASE Language: German Journal: Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie Year: 2023 Document Type: Article